The dose-dependent effects of l-carnitine in myocardial protection in normothermic ischemia

Vascular

Volumn 6, Issue 2, 1998, Pages 145-148

  Tatlican O ^a   Kalaycioglu S ^a   Gokgoz L ^a   Oktar, L ^a   oz E ^a,b   Soncul, H ^a   Sinci, V ^a   Turkozkan N ^a,b   Yener, A ^a   Ersoz A ^a  

^a Gazi University   (Australia)

^b Department of Physiology ^*  (Turkey)

Author keywords

adenosine deaminase; L carnitine; malondialdehyde; myocardial protection; normothermic ischemia

Indexed keywords

CARNITINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE DEAMINASE; ANALYSIS OF VARIANCE; ANIMALS; CARNITINE; CHICK EMBRYO; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART RATE; MALE; MALONDIALDEHYDE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; REFERENCE VALUES;

EID: 0032054183     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099800600207     Document Type: Article

References (15)

1. Rebouche C. J., Paulson J. D., Carnitine metabolism and functions in humans. Annual Review of Nutrition, 1986, 6, 41–66.
2. Bieber L. L., Carnitine. Annual Review of Biochemistry, 1988, 57, 261–283.
3. Rebouche C. J., Sites and regulation of carnitine biosynthesis in mammals. Pediatric Proceedings, 1982, 41, 2848–2852.
4. Pepine C. J., The therapeutic potential of carnitine in cardiovascular disorders. Clinical Therapeutics, 1991, 13(1), 1–21.
5. Fujisawa S., Kobayashi A., Hironaka Y., Yamazaki N., Effect of l-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart. Japanase Heart Journal, 1992, 33(5), 693–705.
6. Packer L., Valenza M., Serbinova E., et al, Free radical scavenging is involved in the protective effect of l-propionylcarnitine against ischemia-reperfusion injury of the heart. Archieves of Biochemistry and Biophysics, 1991, 288(2), 533–537.
7. Uchiyama M., Mihara M., Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Annuals of Biochemistry, 1978, 86, 217–278.
8. Lowry D. H., Rosenburg N. J., Ferr A. I., Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 1951, 44, 193–263.
9. Leipala J. A., Bhatnagar R., Pineda E., et al, Protection of the reperfused heart by l-propionylcarnitine. Journal of Applied Physiologhy, 1989, 71(4), 1518–1522.
10. Soncul H., Tatlýcan O., Halit V., et al, The effect of selenium added cardioplegia in guinea-pigs. General Pharmacology, 1994, 25(7), 1493–1497.
11. Kobayashi A., Suzuki Y., Kamikawa T., et al, Effects of l-camitine on ventricular arrythmias after coronary reperfusion. Japanese Circulation Journal, 1983, 47, 536–542.
12. Rizzon G., Biasco G., Biase M. D. I., et al, High doses of l-carnitine in acute myocardial infarction: Metabolic and antiarrythmic effects. European Heart Journal, 1989, 10, 502–508.
13. Schiavoni G., Pennestri F., Mongiardo R., Cardiodynamic effects of l-camitine in ischemic cardiopathy. Drugs and Experimental Clinical Research, 1983, 9, 171–185.
14. Ino T., Sherwood G., Benson L. N., et al, Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. Journal of American College of Cardiology, 1988, 11, 1301–1308.
15. Rebouche C. J., Engel A. G., Carnitine metabolism and deficiency syndromes. Mayo Clinical Proceedings, 1983, 58, 533–540.